Literature DB >> 10074041

Ipratropium does indeed reduce admissions to hospital with severe asthma.

A Zaritsky, F Qureshi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10074041      PMCID： PMC1115171          DOI： 10.1136/bmj.318.7185.738

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Efficacy of nebulized ipratropium in severely asthmatic children.

Authors:  F Qureshi; A Zaritsky; H Lakkis
Journal:  Ann Emerg Med       Date:  1997-02       Impact factor: 5.721

Review 2.  Should inhaled anticholinergics be added to beta2 agonists for treating acute childhood and adolescent asthma? A systematic review.

Authors:  L H Plotnick; F M Ducharme
Journal:  BMJ       Date:  1998-10-10

3.  Effect of nebulized ipratropium on the hospitalization rates of children with asthma.

Authors:  F Qureshi; J Pestian; P Davis; A Zaritsky
Journal:  N Engl J Med       Date:  1998-10-08       Impact factor: 91.245
  3 in total
  3 in total

1.  Severe acute asthma exacerbation in children: a stepwise approach for escalating therapy in a pediatric intensive care unit.

Authors:  I Federico Fernandez Nievas; Kanwaljeet J S Anand
Journal:  J Pediatr Pharmacol Ther       Date:  2013-04

Review 2.  Anticholinergic agents for chronic asthma in adults.

Authors:  M Westby; M Benson; P Gibson
Journal:  Cochrane Database Syst Rev       Date:  2004

Review 3.  Anticholinergic therapy for chronic asthma in children over two years of age.

Authors:  N J McDonald; A I Bara
Journal:  Cochrane Database Syst Rev       Date:  2003
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.